Literature DB >> 33878123

Human parvovirus B19 interacts with globoside under acidic conditions as an essential step in endocytic trafficking.

Jan Bieri1, Remo Leisi1, Cornelia Bircher1, Carlos Ros1.   

Abstract

The glycosphingolipid (GSL) globoside (Gb4) is essential for parvovirus B19 (B19V) infection. Historically considered the cellular receptor of B19V, the role of Gb4 and its interaction with B19V are controversial. In this study, we applied artificial viral particles, genetically modified cells, and specific competitors to address the interplay between the virus and the GSL. Our findings demonstrate that Gb4 is not involved in the binding or internalization process of the virus into permissive erythroid cells, a function that corresponds to the VP1u cognate receptor. However, Gb4 is essential at a post-internalization step before the delivery of the single-stranded viral DNA into the nucleus. In susceptible erythroid Gb4 knockout cells, incoming viruses were arrested in the endosomal compartment, showing no cytoplasmic spreading of capsids as observed in Gb4-expressing cells. Hemagglutination and binding assays revealed that pH acts as a switch to modulate the affinity between the virus and the GSL. Capsids interact with Gb4 exclusively under acidic conditions and dissociate at neutral pH. Inducing a specific Gb4-mediated attachment to permissive erythroid cells by acidification of the extracellular environment led to a non-infectious uptake of the virus, indicating that low pH-mediated binding to the GSL initiates active membrane processes resulting in vesicle formation. In summary, this study provides mechanistic insight into the interaction of B19V with Gb4. The strict pH-dependent binding to the ubiquitously expressed GSL prevents the redirection of the virus to nonpermissive tissues while promoting the interaction in acidic intracellular compartments as an essential step in infectious endocytic trafficking.

Entities:  

Year:  2021        PMID: 33878123     DOI: 10.1371/journal.ppat.1009434

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  4 in total

1.  Prevalence, Cell Tropism, and Clinical Impact of Human Parvovirus Persistence in Adenomatous, Cancerous, Inflamed, and Healthy Intestinal Mucosa.

Authors:  Man Xu; Katarzyna Leskinen; Tommaso Gritti; Valerija Groma; Johanna Arola; Anna Lepistö; Taina Sipponen; Päivi Saavalainen; Maria Söderlund-Venermo
Journal:  Front Microbiol       Date:  2022-05-24       Impact factor: 6.064

2.  Disseminated Human Parvovirus B19 Infection Induced Multiple Organ Dysfunction Syndrome in an Adult Patient With Alcoholic Hepatitis Complicated by Hemolytic Anemia: A Case Report and Literature Review.

Authors:  Jinmei Luo; Jingcong Zhang; Wenxing Lai; Shaofang Wang; Laizhi Zhou; Yunfeng Shi; Junhui Ba; Jiajia Hu; Yanhong Wang; Laisheng Li; Ben-Quan Wu
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

Review 3.  Microbial lectome versus host glycolipidome: How pathogens exploit glycosphingolipids to invade, dupe or kill.

Authors:  Anna Bereznicka; Krzysztof Mikolajczyk; Marcin Czerwinski; Radoslaw Kaczmarek
Journal:  Front Microbiol       Date:  2022-08-19       Impact factor: 6.064

4.  Structural Dynamics and Activity of B19V VP1u during the pHs of Cell Entry and Endosomal Trafficking.

Authors:  Renuk V Lakshmanan; Joshua A Hull; Luke Berry; Matthew Burg; Brian Bothner; Robert McKenna; Mavis Agbandje-McKenna
Journal:  Viruses       Date:  2022-08-30       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.